Paul Gallagher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Paul Gallagher has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Alfonso J. Cruz-Jentoft
Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
2 shared publications - Antonio Cherubini
Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, 60126 Ancona, Italy
2 shared publications - Beatrice Gasperini
Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy
2 shared publications D O'Mahony
Cork University Hospital Department of Geriatric Medicine Cork Ireland
2 shared publicationsDenis O'MAhony
2 shared publications- Denis O'Mahony
University College Cork, Cork, Ireland
2 shared publications
Latest Publications
- Open Access
- 1 September 2017
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 46 (Suppl_3) , iii1-iii12
278Medication Burden in the Last Year of Life
An important principle of patient-centred care is to match interventions and medications to a patient’s overall condition and goals of care. STOPPfrail is a validated explicit list of medications that are potentially inappropriate in older people with high morbidity and poor one-year survival prognosis. An acute hospital admission is an opportunity to optimise prescribing. The aim of this study was to determine the prevalence of STOPPfrail potentially inappropriate medications (PIMs) amongst patients discharged from hospital in the last year of life. In addition, we aimed to measure the total number of medications consumed by patients while in hospital in the last year of life.
- 1 September 2017
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 46 (Suppl_3) , iii1-iii12
Open Access278Medication Burden in the Last Year of Life
An important principle of patient-centred care is to match interventions and medications to a patient’s overall condition and goals of care. STOPPfrail is a validated explicit list of medications that are potentially inappropriate in older people with high morbidity and poor one-year survival prognosis. An acute hospital admission is an opportunity to optimise prescribing. The aim of this study was to determine the prevalence of STOPPfrail potentially inappropriate medications (PIMs) amongst patients discharged from hospital in the last year of life. In addition, we aimed to measure the total number of medications consumed by patients while in hospital in the last year of life.
- 28 November 2011
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 171 (21) , 1960-1961
Adverse Drug Events Due to Potentially Inappropriate Medications—Reply
In reply We note the comments of Drs Sakuma and Morimoto, suggesting caution when interpreting the data in our study published in the Archives on June 13.1 Their first point refers to “retrospectively collected” ADE data in our study. This was not the case. Data were collected prospectively at the point of admission, when World Health Organization–Uppsala Monitoring Committee (WHO-UMC) criteria for ADE detection were applied. Only those cases in which WHO-UMC criteria indicated a “probable” or “definite” ADE on admission to hospital were considered by the local expert panel for determination of whether the ADE was causal or contributory to the index hospitalization or an incidental finding. Furthermore, the local expert panel were not aware of whether these patients were taking Beers or STOPP criteria PIMs during their deliberations on the presence or absence of ADEs.
- 28 November 2011
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 171 (21) , 1960-1961
Adverse Drug Events Due to Potentially Inappropriate Medications—Reply
In reply We note the comments of Drs Sakuma and Morimoto, suggesting caution when interpreting the data in our study published in the Archives on June 13.1 Their first point refers to “retrospectively collected” ADE data in our study. This was not the case. Data were collected prospectively at the point of admission, when World Health Organization–Uppsala Monitoring Committee (WHO-UMC) criteria for ADE detection were applied. Only those cases in which WHO-UMC criteria indicated a “probable” or “definite” ADE on admission to hospital were considered by the local expert panel for determination of whether the ADE was causal or contributory to the index hospitalization or an incidental finding. Furthermore, the local expert panel were not aware of whether these patients were taking Beers or STOPP criteria PIMs during their deliberations on the presence or absence of ADEs.
- 17 May 2011
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 67 (11) , 1175-1188
Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals
Potentially inappropriate prescribing is common in older people presenting to hospital with acute illness in Ireland. The aim of this study was to determine if this phenomenon is unique to Ireland or whether it is a more widespread problem in hospitals across Europe. Prospective data were collected from 900 consecutive older patients admitted to six university teaching hospitals (150 patients per centre) in Geneva (Switzerland), Madrid (Spain), Oostende (Belgium), Perugia (Italy), Prague (Czech Republic) and Cork (Ireland). Age, gender, comorbidity, cognitive status, prescription medicines taken before admission and baseline haematological, biochemical and electrocardiographic data were recorded. STOPP and Beers’ criteria were applied to detect potentially inappropriate medicines (PIMs). START criteria were applied to detect potentially inappropriate prescribing omissions (PPOs). The overall PIM prevalence rate was 51.3% using STOPP criteria, varying from 34.7% in Prague to 77.3% in Geneva, and 30.4% using Beer’s criteria, varying from 22.7% in Prague to 43.3% in Geneva. Using START criteria, the overall PPO prevalence rate was 59.4%, ranging from 51.3% in Cork to 72.7% in Perugia. Polypharmacy predicted the presence of PIMs using STOPP criteria [with >10 medications: odds ratio (OR) 7.22, 95% confidence interval (CI) 4.30–12.12, p < 0.001] and Beers’ criteria (with >10 medications: OR 4.87, 95% CI 3.00–7.90, p < 0.001). Increasing co-morbidity (Charlson Index ≥2) and age ≥85 years significantly predicted PPOs. Potentially inappropriate drug prescribing and the omission of beneficial drugs are highly prevalent in acutely ill hospitalized older people in six European centres.
- 17 May 2011
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 67 (11) , 1175-1188
Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals
Potentially inappropriate prescribing is common in older people presenting to hospital with acute illness in Ireland. The aim of this study was to determine if this phenomenon is unique to Ireland or whether it is a more widespread problem in hospitals across Europe. Prospective data were collected from 900 consecutive older patients admitted to six university teaching hospitals (150 patients per centre) in Geneva (Switzerland), Madrid (Spain), Oostende (Belgium), Perugia (Italy), Prague (Czech Republic) and Cork (Ireland). Age, gender, comorbidity, cognitive status, prescription medicines taken before admission and baseline haematological, biochemical and electrocardiographic data were recorded. STOPP and Beers’ criteria were applied to detect potentially inappropriate medicines (PIMs). START criteria were applied to detect potentially inappropriate prescribing omissions (PPOs). The overall PIM prevalence rate was 51.3% using STOPP criteria, varying from 34.7% in Prague to 77.3% in Geneva, and 30.4% using Beer’s criteria, varying from 22.7% in Prague to 43.3% in Geneva. Using START criteria, the overall PPO prevalence rate was 59.4%, ranging from 51.3% in Cork to 72.7% in Perugia. Polypharmacy predicted the presence of PIMs using STOPP criteria [with >10 medications: odds ratio (OR) 7.22, 95% confidence interval (CI) 4.30–12.12, p < 0.001] and Beers’ criteria (with >10 medications: OR 4.87, 95% CI 3.00–7.90, p < 0.001). Increasing co-morbidity (Charlson Index ≥2) and age ≥85 years significantly predicted PPOs. Potentially inappropriate drug prescribing and the omission of beneficial drugs are highly prevalent in acutely ill hospitalized older people in six European centres.
- Top Cited Papers
- 20 April 2011
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 89 (6) , 845-854
Prevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria
Inappropriate prescribing is particularly common in older patients and is associated with adverse drug events (ADEs), hospitalization, and wasteful utilization of resources. We randomized 400 hospitalized patients aged ≥ 65 years to receive either the usual pharmaceutical care (control) or screening with STOPP/START criteria followed up with recommendations to their attending physicians (intervention). The Medication Appropriateness Index (MAI) and Assessment of Underutilization (AOU) index were used to assess prescribing appropriateness, both at the time of discharge and for 6 months after discharge. Unnecessary polypharmacy, the use of drugs at incorrect doses, and potential drug-drug and drug-disease interactions were significantly lower in the intervention group at discharge (absolute risk reduction 35.7%, number needed to screen to yield improvement in MAI = 2.8 (95% confidence interval 2.2-3.8)). Underutilization of clinically indicated medications was also reduced (absolute risk reduction 21.2%, number needed to screen to yield reduction in AOU = 4.7 (95% confidence interval 3.4-7.5)). Significant improvements in prescribing appropriateness were sustained for 6 months after discharge.
- 20 April 2011
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 89 (6) , 845-854
Top Cited PapersPrevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria
Inappropriate prescribing is particularly common in older patients and is associated with adverse drug events (ADEs), hospitalization, and wasteful utilization of resources. We randomized 400 hospitalized patients aged ≥ 65 years to receive either the usual pharmaceutical care (control) or screening with STOPP/START criteria followed up with recommendations to their attending physicians (intervention). The Medication Appropriateness Index (MAI) and Assessment of Underutilization (AOU) index were used to assess prescribing appropriateness, both at the time of discharge and for 6 months after discharge. Unnecessary polypharmacy, the use of drugs at incorrect doses, and potential drug-drug and drug-disease interactions were significantly lower in the intervention group at discharge (absolute risk reduction 35.7%, number needed to screen to yield improvement in MAI = 2.8 (95% confidence interval 2.2-3.8)). Underutilization of clinically indicated medications was also reduced (absolute risk reduction 21.2%, number needed to screen to yield reduction in AOU = 4.7 (95% confidence interval 3.4-7.5)). Significant improvements in prescribing appropriateness were sustained for 6 months after discharge.
- 1 December 2009
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 23 (6) , 875-887
Constipation in old age
- 1 December 2009
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 23 (6) , 875-887
Constipation in old age
- Open Access
- 12 May 2009
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 38 (5) , 603-606
Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries
SIR—Inappropriate prescribing (IP) encompasses the use of medicines where the risk of an adverse drug event (ADE) outweighs the clinical benefit, particularly when safer or more effective alternatives are available [ 1, 2 ]. IP also includes the use of medicines that increase the likelihood of drug–drug and drug–disease interactions, the mis-prescribing of medicines (incorrect dose, frequency and duration) and the under-use of clinically indicated medicines [ 3–5 ]. IP is highly prevalent in older people and has been associated with preventable ADEs, hospitalisation, institutionalisation, death and resource wastage [ 6–12 ]. With increasing proportions of older people worldwide, quality and safety of prescribing are becoming a global healthcare concern [ 5 , 13 ].
- 12 May 2009
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 38 (5) , 603-606
Open AccessInter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries
SIR—Inappropriate prescribing (IP) encompasses the use of medicines where the risk of an adverse drug event (ADE) outweighs the clinical benefit, particularly when safer or more effective alternatives are available [ 1, 2 ]. IP also includes the use of medicines that increase the likelihood of drug–drug and drug–disease interactions, the mis-prescribing of medicines (incorrect dose, frequency and duration) and the under-use of clinically indicated medicines [ 3–5 ]. IP is highly prevalent in older people and has been associated with preventable ADEs, hospitalisation, institutionalisation, death and resource wastage [ 6–12 ]. With increasing proportions of older people worldwide, quality and safety of prescribing are becoming a global healthcare concern [ 5 , 13 ].
- 11 February 2009
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 85 (5) , 472
Inappropriate Medications and Adverse Drug Reactions in the Elderly
- 11 February 2009
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 85 (5) , 472
Inappropriate Medications and Adverse Drug Reactions in the Elderly
- Top Cited PapersOpen Access
- 1 October 2008
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 37 (6) , 673-679
STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria
Introduction: STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions) is a new, systems-defined medicine review tool. We compared the performance of STOPP to that of established Beers’ criteria in detecting potentially inappropriate medicines (PIMs) and related adverse drug events (ADEs) in older patients presenting for hospital admission. Methods: we prospectively studied 715 consecutive acute admissions to a university teaching hospital. Diagnoses, reason for admission and concurrent medications were recorded. STOPP and Beers’ criteria were applied. PIMs with clear causal connection or contribution to the principal reason for admission were determined. Results: median patient age (interquartile range) was 77 (72–82) years. Median number of prescription medicines was 6 (range 0–21). STOPP identified 336 PIMs affecting 247 patients (35%), of whom one-third (n = 82) presented with an associated ADE. Beers’ criteria identified 226 PIMs affecting 177 patients (25%), of whom 43 presented with an associated ADE. STOPP-related PIMs contributed to 11.5% of all admissions. Beers’ criteria-related PIMs contributed to significantly fewer admissions (6%). Conclusion: STOPP criteria identified a significantly higher proportion of patients requiring hospitalisation as a result of PIM-related adverse events than Beers’ criteria. This finding has significant implications for hospital geriatric practice.
- 1 October 2008
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 37 (6) , 673-679
Top Cited PapersOpen AccessSTOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria
Introduction: STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions) is a new, systems-defined medicine review tool. We compared the performance of STOPP to that of established Beers’ criteria in detecting potentially inappropriate medicines (PIMs) and related adverse drug events (ADEs) in older patients presenting for hospital admission. Methods: we prospectively studied 715 consecutive acute admissions to a university teaching hospital. Diagnoses, reason for admission and concurrent medications were recorded. STOPP and Beers’ criteria were applied. PIMs with clear causal connection or contribution to the principal reason for admission were determined. Results: median patient age (interquartile range) was 77 (72–82) years. Median number of prescription medicines was 6 (range 0–21). STOPP identified 336 PIMs affecting 247 patients (35%), of whom one-third (n = 82) presented with an associated ADE. Beers’ criteria identified 226 PIMs affecting 177 patients (25%), of whom 43 presented with an associated ADE. STOPP-related PIMs contributed to 11.5% of all admissions. Beers’ criteria-related PIMs contributed to significantly fewer admissions (6%). Conclusion: STOPP criteria identified a significantly higher proportion of patients requiring hospitalisation as a result of PIM-related adverse events than Beers’ criteria. This finding has significant implications for hospital geriatric practice.
- 18 April 2008
- Published by Elsevier in Journal of Tissue Viability
- Vol. 17 (4) , 103-109
Prevalence of pressure ulcers in three university teaching hospitals in Ireland
- 18 April 2008
- Published by Elsevier in Journal of Tissue Viability
- Vol. 17 (4) , 103-109
Prevalence of pressure ulcers in three university teaching hospitals in Ireland
- 1 March 2008
- Vol. 101 (3) , 70-2
Do relatives of elderly patients block the discharge process?
There is a perception that relatives of older patients "block" their discharge from acute hospitals, thereby compounding the capacity crises of Ireland's A+E departments. This study prospectively analyses 1,240 consecutive referrals to the discharge co-ordinator of an acute general hospital over a two-year period. The number of bed-days consumed by all patients whose discharge was delayed was calculated, in addition to reasons for delay and whether or not patients' relatives were opposing discharge. There were 90 cases of delayed discharge resulting in 2,436 bed-days consumed over the study period. Reasons for delays principally centred on access to long-term care facilities and organisation of community supports. Patients' relatives opposed discharge in 9 of the 90 delayed cases. Concerns expressed by patients' relatives reflected the paucity of community supports available for older people and their carers. Older people's relatives are patient advocates and seek appropriate facilities for those whom they represent.
- 1 March 2008
- Vol. 101 (3) , 70-2
Do relatives of elderly patients block the discharge process?
There is a perception that relatives of older patients "block" their discharge from acute hospitals, thereby compounding the capacity crises of Ireland's A+E departments. This study prospectively analyses 1,240 consecutive referrals to the discharge co-ordinator of an acute general hospital over a two-year period. The number of bed-days consumed by all patients whose discharge was delayed was calculated, in addition to reasons for delay and whether or not patients' relatives were opposing discharge. There were 90 cases of delayed discharge resulting in 2,436 bed-days consumed over the study period. Reasons for delays principally centred on access to long-term care facilities and organisation of community supports. Patients' relatives opposed discharge in 9 of the 90 delayed cases. Concerns expressed by patients' relatives reflected the paucity of community supports available for older people and their carers. Older people's relatives are patient advocates and seek appropriate facilities for those whom they represent.